ライフサイエンスコーパス: phosphoprotein

1 A expression of VASP (vasodilator-stimulated phosphoprotein).

2 ed kinase), and VASP (vasodilator-stimulated phosphoprotein).

3 rotubule-associated protein tau is an axonal phosphoprotein.

4 lls through nonstructural protein 2 (NS2), a phosphoprotein.

5 he TJ binding protein vasodilator-stimulated phosphoprotein.

6 ylation of Ser-239 in vasodilator-stimulated phosphoprotein.

7 t reactivity index by vasodilator-stimulated phosphoprotein.

8 e information is available on HAI1-regulated phosphoproteins.

9 by general methods to biosynthesize defined phosphoproteins.

10 rotein 79 (AKAP79) delineates PP2B access to phosphoproteins.

11 orylation in both phosphopeptides and intact phosphoproteins.

12 d mass spectrometry analysis of the enriched phosphoproteins.

13 , respectively, both the PSII core and LHCII phosphoproteins.

14 ifically bind to the phosphate groups on any phosphoproteins.

15 enic markers, alkaline phosphatase, secreted phosphoprotein 1 (osteopontin), and bone gamma-carboxygl

16 s SNPs associated with Src kinase-associated phosphoprotein 1 (SKAP1), matrix metallopeptidase 12 (MM

17 L1 directly bound to the proform of secreted phosphoprotein 1 (SPP1)/osteopontin, restraining proteol

18 Secreted phosphoprotein 1 (SPP1, also known as osteopontin) incre

19 ivision cycle 37 (Cdc37), and stress induced phosphoprotein 1 (STIP1) in a pattern that is consistent

20 Secreted phosphoprotein 1 and sex-specific differences in silica-

21 Pb induced the expression of SPP1 (secreted phosphoprotein 1), which has known neuroprotective effec

22 ntin dysplasia targets (Dentin matrix acidic phosphoprotein 1).

23 RNA expression levels of secreted phosphoprotein 1, the gene that encodes OPN, correlate w

24 terix, osteocalcin, and dentin matrix acidic phosphoprotein 1.

25 arboxyl terminal region of BTV nonstructural phosphoprotein 2 (NS2).

26 7804356 located in the Src kinase-associated phosphoprotein 2 (SKAP2) gene is associated with type 1

27 The Src kinase-associated phosphoprotein 2 (Skap2) is involved in integrin functio

28 conserved disulfide bonded loop of secreted phosphoprotein 2 (Spp-24) encoded by SPP2.

29 spersal response (GDR), which uses the Golgi phosphoprotein 3 (GOLPH3)-DNA-dependent protein kinase (

30 lls gain metastatic capacity through a Golgi phosphoprotein 3-dependent (GOLPH3-dependent) Golgi memb

31 ecies-specific differences in acidic nuclear phosphoprotein 32 (ANP32), a family of essential host pr

32 Dopamine and cAMP regulated phosphoprotein 32 kDa (DARPP-32) also known as phosphopr

33 cAMP], dopamine- and cAMP-regulated neuronal phosphoprotein 32 kDa [DARPP-32], and cAMP responsive el

34 ne and abnormal dopamine- and cAMP-regulated phosphoprotein 32 kDa signal integration.

35 ngtin/DARPP-32 (dopamine- and cAMP-regulated phosphoprotein 32) knock-in mutant mouse was generated t

36 filamentous actin (F-actin) and ERM-binding phosphoprotein 50 (EBP50).

37 ; also known as ezrin-radixin-moesin-binding phosphoprotein 50) is a PSD-95, disc large, zona occlude

38 proposed that B cell epitope region of HCMV phosphoprotein 65 (HCMVpp65)(422-439) mimics an endogeno

39 ells with an overlapping peptide pool of CMV phosphoprotein 65 (pp65) and immediate early-1 (IE-1) pr

40 ination with DCs pulsed with Cytomegalovirus phosphoprotein 65 (pp65) RNA.

41 CMV phosphoprotein 65 (pp65)- and immediate early protein 1-

42 fit of adoptive T-cell therapy (ATCT) of CMV phosphoprotein 65 (pp65)-specific T cells.

43 significantly rescued, most effectively with phosphoprotein 65 Ag and combined exogenous IL-2 and IL-

44 s) were >100 (cutoff 1) or when the IE-1 and phosphoprotein 65 antigen SPCs were both >100 SPCs per 2

45 -specific CTLs responded specifically to CMV-phosphoprotein 65 stimulation by secreting IFN-gamma and

46 e early 1 or 100 spots per 250 000 cells for phosphoprotein 65) identified patients who were protecte

47 However, the capacity for in vitro CMV phosphoprotein 65-specific proliferation and CD4(+)T-bet

48 hort that were specific for epitopes of HCMV phosphoprotein-65, tetanus toxoid precursor, EBV nuclear

49 rge, the enzymatic component) protein and P (phosphoprotein, a cofactor component).

50 i) baseline correlations between protein and phosphoprotein abundances, (ii) universal protein-protei

51 dence that lack of secretory calcium-binding phosphoproteins accounts for the evolutionary loss of sc

52 Phosphoprotein activation of several MAPK signaling comp

53 ion with inflammatory cells, while decreased phosphoproteins after 7d oral dosing was consistent with

54 Scc2 is a phosphoprotein, although the functions of phosphorylatio

55 Nipah virus (NiV) phosphoprotein, an essential component of the viral RNA

56 ids followed by quantitative phenotyping and phosphoprotein analyses uncover key changes in the signa

57 In addition, FDH is a phosphoprotein and dephosphorylation was found to increa

58 reveal new paradigms for ANDV N protein as a phosphoprotein and IFN pathway regulator and suggest new

59 RCM-1 is a phosphoprotein and is a substrate of PKA in vivo and in

60 nt protein (EGFP) was introduced between the phosphoprotein and matrix genes (position 5) of the geno

61 hosphorylated, newly classifying ANDV N as a phosphoprotein and phosphorylated S386 as a unique deter

62 new, to our knowledge, insights into how the phosphoprotein and the nonstructural V and W proteins of

63 Furthermore, PPM1G is a phosphoprotein and this phosphorylation appears to be re

64 We biosynthesize several phosphoproteins and demonstrate phosphoprotein structure

65 ecently, we developed an approach to isolate phosphoproteins and glycoproteins in EVs from small volu

66 conservation of the LC8 motif in Lyssavirus phosphoproteins and its presence in other analogous prot

67 relative abundance of thousands of proteins, phosphoproteins and phosphorylation sites specific to ea

68 tein (DSPP) into dentin sialoprotein, dentin phosphoprotein, and dentin glycoprotein.

69 clusion bodies containing the nucleoprotein, phosphoprotein, and respective viral genomic RNA were cl

70 ily of evolutionary conserved acidic nuclear phosphoproteins (ANP32A-H).

71 roach, we show that the human acidic nuclear phosphoproteins (ANPs) ANP32A and ANP32B are functionall

72 Phosphoprotein antibody array analysis revealed that PL

73 ay in Dajiao, along with other cold-specific phosphoproteins, appears to be associated with the molec

74 Characteristic phosphopeptides of phosphoproteins are identified from human serum after th

75 Phosphoproteins are the key indicators of signaling netw

76 zation from synapses, thereby indicating the phosphoprotein as a novel target through which S1P contr

77 hemistry, we identify more than 100 secreted phosphoproteins as genuine Fam20C substrates.

78 The identity and localization of the phosphoproteins as well as enrichment of specific phosph

79 eactivity test, and a vasodilator-stimulated phosphoprotein assay.

80 Protein lysates were processed for phosphoprotein assays and a wound healing assay performe

81 tance aggregometry or vasodilator-stimulated phosphoprotein assays, was numerically but not significa

82 proteins, can reinvigorate studies of 14-3-3/phosphoprotein assemblies, including those with challeng

83 Phosphoprotein associated with glycosphingolipid-enriche

84 binding to a transmembrane adaptor known as phosphoprotein associated with glycosphingolipid-enriche

85 Phosphoproteins associated with insulin, erb-b2 receptor

86 remained limited by our inability to produce phosphoproteins at high yields.

87 Thus, a phosphoprotein-based diagnostic assay combined with Cdk5

88 The results for phosphoprotein beta-casein show that, under mild subcrit

89 The 14-3-3 family of phosphoprotein-binding proteins regulates many cellular

90 ic screens have revealed many Rab GTPases as phosphoproteins, but the effects of this modification ar

91 Pin1 regulates the levels and functions of phosphoproteins by catalyzing phosphorylation-dependent

92 However, standard methods of phosphoprotein characterisation are largely unsuitable f

93 rom a recombinant baculovirus vector and the phosphoprotein cofactor (P) in Escherichia coli and puri

94 complete structure of RABV L bound with its phosphoprotein cofactor (P), determined by electron cryo

95 ) and the X domain (XD) of the measles virus phosphoprotein complex.

96 those differences in the membrane-associated phosphoproteins composition were associated with various

97 itration calorimetry, we map a region of the phosphoprotein, comprising residues between 110 and 140

98 atform for direct expression of programmable phosphoproteins containing multiple phosphorylated resid

99 e and drug-induced changes in the metabolite-phosphoprotein correlation network.

100 pVASP (phosphorylated vasodilator stimulated phosphoprotein), cortactin and vinculin.

101 e assigned all phosphorylation sites to 3013 phosphoproteins, covering the entire dynamic range from

102 ion of dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32) exclusively in D2R-expressing

103 rons expressing dopamine- and cAMP-regulated phosphoprotein (DARPP-32+), known to be modulated by dop

104 We used phosphoprotein data from cancer cell lines as well as in

105 Integration of mRNA, protein, and phosphoprotein data sets greatly improved the predictive

106 Using the phosphoprotein data, we scored more than 2,000 networks

107 ublished pseudopodium-enriched (PDE) protein/phosphoprotein datasets to identify novel PDAC-specific

108 are dissociated by WNTs and regulated by the phosphoprotein Dishevelled (DVL).

109 functional interaction between FZDs and the phosphoprotein Dishevelled, supporting conformational se

110 (DSP), dentin glycoprotein (DGP) and dentin phosphoprotein (DPP).

111 We have identified a previously unidentified phosphoprotein encoded by MDV ORF012.

112 hat neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at approximately 1

113 Global phosphoprotein enrichment analysis revealed involvement

114 we performed and compared phosphopeptide and phosphoprotein enrichment methodologies after activation

115 Phosphopeptides/phosphoproteins enrichment from biological samples is cu

116 he late endosome in a vasodilator-stimulated phosphoprotein envelope.

117 However, several protein/phosphoprotein events such as overexpression of AKT prot

118 lisib) to determine their impact on mRNA and phosphoprotein expression, as well as their functional e

119 ins of the Mena/VASP (vasodilator-stimulated phosphoprotein) family.

120 ssociations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, and protein-disul

121 rosylation, including vasodilator-stimulated phosphoprotein, focal adhesion kinase, the membrane phos

122 ated RABV expressing the glycoprotein or the phosphoprotein from wt RABV) demonstrate that DC activat

123 These NPs enrich phosphoproteins from complex cell and tissue lysates wit

124 der purpose for LC8 in regulating downstream phosphoprotein functions vital for viral replication.

125 Synapsins are a family of phosphoproteins fundamental to the regulation of neurotr

126 isruptions in mitochondria, RNA splicing and phosphoprotein gene pathways.

127 identical to those of the nucleoprotein and phosphoprotein genes except that it contains an apparent

128 RNAs), 17,862 nonmodified proteins, and 6227 phosphoproteins harboring 31,595 phosphorylation sites q

129 The existence of extracellular phosphoproteins has been acknowledged for over a century

130 Although numerous extracellular phosphoproteins have been identified, the protein kinase

131 nfection and requires an active large T (LT) phosphoprotein helicase to replicate.

132 minal EVH1 (Ena/VASP [vasodilator-stimulated phosphoprotein] homology domain 1) binding domains of Lp

133 Of the 1112 membrane-associated phosphoproteins identified, 64 and 243 were classified a

134 Phosphoprotein IHC have been impractical for diagnostics

135 astatic gastrointestinal tumors (n = 28) for phosphoprotein IHC markers pAKT, pERK, pSRC, pSTAT3, and

136 d plus warm formalin fixation protocol using phosphoproteins IHC.

137 rotein (TPBG), as a novel PKCalpha-dependent phosphoprotein in retinal rod bipolar cells (RBCs).

138 Phospholamban is a small phosphoprotein in the cardiac sarcoplasmic reticulum, an

139 role of a disordered secondary structure in phosphoproteins in bone-like apatite formation.

140 al phosphorylation dynamics of 1,887 cardiac phosphoproteins in early affected heart tissue in a tran

141 oach offered broader inhibition of genes and phosphoproteins in the PI3K/mTOR pathway, when compared

142 of cocaine-induced dephosphorylation of key phosphoproteins in the prefrontal cortex related to syna

143 e for phosvitin, an intrinsically disordered phosphoprotein, in chick embryo skeletal development, an

144 Nuclear accumulation of the small phosphoprotein integrin cytoplasmic domain-associated pr

145 20), is critical for coordinating 14-3-3zeta-phosphoprotein interactions.

146 le, and osteopontin (OPN), a multifunctional phosphoprotein involved in neutrophil activation, compar

147 study, we identify Synapsin I, a presynaptic phosphoprotein involved in the control of availability o

148 Phosducin (Pdc), a highly conserved phosphoprotein involved in the regulation of retinal pho

149 Numerous phosphoproteins involved in actin dynamics including Wis

150 Phosphopeptide abundances of five phosphoproteins involved in MKK2 interaction network, in

151 We show that full-length NiV phosphoprotein is tetrameric, and we solve the crystal s

152 Phosphoprotein is the main cofactor of the viral RNA pol

153 hment of pY-containing peptides derived from phosphoproteins is commonly facilitated by use of immobi

154 (GAP43), a protein kinase C (PKC)-activated phosphoprotein, is often implicated in axonal plasticity

155 that Nopp140, an intrinsically disordered CB phosphoprotein, is required to recruit and retain all sc

156 with the v-ATPase and the associated LAMTOR1 phosphoprotein, key components of the lysosomal nutrient

157 Mononegavirales phosphoproteins lack sequence conservation, but contain

158 Phosphoprotein levels were tested for association with g

159 RGS9-2 affects several protein interactions, phosphoprotein levels, and the function of the epigeneti

160 sessments measured by vasodilator-stimulated phosphoprotein, light transmittance aggregometry, and Mu

161 ding VerifyNow P2Y12, vasodilator-stimulated phosphoprotein, light transmittance aggregometry, and Mu

162 While acidic phosphoproteins, localized in the mineralized tissues, p

163 Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32), is frequently overe

164 and cyclic adenosine monophosphate-regulated phosphoprotein, Mr 32000) in promoting tumor growth thro

165 We previously identified the centrosomal phosphoprotein NDE1 as a negative regulator of ciliary l

166 or control flicker and assessed cytokine and phosphoprotein networks known to play a role in immune f

167 Furthermore, the nucleolar phosphoprotein nucleophosmin (NPM1) acts as a scaffold f

168 In consonance, phosphoproteins obtained after co-expression of PknA wit

169 rons expressing dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP32) or tyrosine hydroxyla

170 lling, dopamine- and cAMP-regulated neuronal phosphoprotein of 32 kDa feedback, and synaptic plastici

171 n Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76) plays a crucial role i

172 The phosphoprotein of human metapneumovirus (HMPV) forms hom

173 Curiously, the phosphoprotein of NiV is significantly longer than the c

174 ly disordered regions account for 80% of the phosphoprotein of the respiratory syncytial virus.

175 enriched within the microenvironment and the phosphoproteins of CD147.

176 cluster at 4q13 encodes structurally related phosphoproteins of which some are specifically expressed

177 c VHSVs in which viral nucleoprotein (N), P (phosphoprotein), or M (matrix protein) genes, or the N a

178 The glyco-phosphoprotein osteopontin (OPN), encoded by the SPP1 ge

179 The phosphoprotein osteopontin is important for critical phy

180 The rabies virus (RABV) phosphoprotein P is a multifunctional protein: it plays

181 eplication and transcription, the tetrameric phosphoprotein P serves as a crucial adaptor between the

182 n a monomeric and RNA-free form by the viral phosphoprotein P that plays the role of a chaperone prot

183 ome of them are multifunctional, such as the phosphoprotein P.

184 urn, suppresses RABV by interacting with its phosphoprotein (P protein) and thus blocking the dimeriz

185 we found that IIGP1 could interact with RABV phosphoprotein (P protein).

186 In addition, copies of the phosphoprotein (P) and the large RNA polymerase (L) deco

187 We find that the viral nucleoprotein (N) and phosphoprotein (P) are sufficient to trigger MeV phase s

188 th and inhibits the function of a particular phosphoprotein (P) component of the viral transcription

189 lytic subunit large protein (L) and cofactor phosphoprotein (P) constitute the Mononegavirales polyme

190 surprisingly, the viral nucleocapsid (N) and phosphoprotein (P) genes together contain the determinan

191 e L(RdRP), L(PRNT), and L(MT), an oligomeric phosphoprotein (P) is required.

192 The phosphoprotein (P) is the main and essential cofactor of

193 ucture of an intermediate of the X domain of phosphoprotein (P) of measles virus.

194 nucleocapsid protein (N) and associated by a phosphoprotein (P) with the large polymerase protein (L)

195 es, minimally composed of nucleoprotein (N), phosphoprotein (P), and viral RNA (vRNA), indicating tha

196 f a 250 kDa large (L) protein and tetrameric phosphoprotein (P), catalyzes three distinct enzymatic a

197 A polymerase, and a polymerase cofactor, the phosphoprotein (P), for transcription and replication.

198 lysis in HEp-2 cells, the nucleoprotein (N), phosphoprotein (P), matrix protein (M), and fusion prote

199 IM69 physically associates with the VSV(IND) phosphoprotein (P), requiring a specific peptide target

200 polymerase protein (L) and its cofactor, the phosphoprotein (P), which associate with the viral ribon

201 uV consists of the large protein (L) and the phosphoprotein (P), while the nucleocapsid protein (NP)

202 endent RNA polymerase (L) and the tetrameric phosphoprotein (P).

203 t of the enzymatic large protein (L) and the phosphoprotein (P).

204 onstituent of the replication machinery, the phosphoprotein (P).

205 of the large polymerase subunit (L) and the phosphoprotein (P).

206 he large protein (L) and the homo-tetrameric phosphoprotein (P).

207 nzymatic functions and an essential coenzyme phosphoprotein (P).

208 ein kinase A) phospho-vasodilator-stimulated phosphoprotein (p-VASP) by isoproterenol (ISO), prostagl

209 ly with their cognate nucleoproteins (N) and phosphoproteins (P).

210 ical enrichment analysis of the differential phosphoprotein patterns revealed selective perturbation

211 The small phosphoprotein pCPI-17 inhibits myosin light-chain phosp

212 se findings advance our understanding of the phosphoproteins, pharmacological responses, and cellular

213 a ubiquitously expressed phosphatase in the phosphoprotein phosphatase (PPP) family.

214 als PP5 utilization of conserved elements of phosphoprotein phosphatase (PPP) structure to bind subst

215 18 and 24 months following control, BDNF or phosphoprotein phosphatase 1 derivative (1NMPP1) treatme

216 Phosphoprotein phosphatase 4 (PP4) has been recently sho

217 Phosphoprotein phosphatase 4 (PP4) is a conserved and es

218 Phosphoprotein phosphatase-1 derivatives such as 1NMPP1

219 osphoprotein 32 kDa (DARPP-32) also known as phosphoprotein phosphatase-1 regulatory subunit 1B and e

220 The reciprocal regulation of phosphoprotein phosphatases (PPPs) by protein kinases is

221 Phosphoprotein phosphatases (PPPs) that dephosphorylate

222 nchoring proteins direct protein kinases and phosphoprotein phosphatases toward selected substrates t

223 Similarly, global inhibition of phosphoprotein phosphatases with orthovanadate or fluori

224 ar Pi concentration, which directly inhibits phosphoprotein phosphatases, triggering a global increas

225 PP7, and PP7-long constitute a subfamily of phosphoprotein phosphatases.

226 ophosphate (cAMP) and vasodilator-stimulated phosphoprotein phosphorylation (VASP-P).

227 Inhibition of vasodilator-stimulated phosphoprotein phosphorylation and prostaglandin E1-indu

228 correlations with the vasodilator-stimulated phosphoprotein phosphorylation assay.

229 rachidonic acid), and vasodilator-stimulated phosphoprotein phosphorylation assays.

230 onfirmed by increased vasodilator-stimulated phosphoprotein phosphorylation in MRP4-deficient platele

231 APTITUDE-CABG) study, vasodilator-stimulated phosphoprotein-platelet reactivity index, a specific mar

232 tratification and CMI specific to the 65 kDa phosphoprotein (pp65) CMV antigen were investigated.

233 s antigens glycoprotein B (gB) and the 65-kD phosphoprotein (pp65), respectively, is in development t

234 ly, suggested that PstP may regulate diverse phosphoproteins, preferentially at phosphothreonine near

235 rapid cold preservation shows improvement in phosphoprotein preservation.

236 The key genes, phosphoproteins, processes, and pathways affected by efa

237 ide network of highly dynamic changes in the phosphoprotein profile of genotoxin-treated cells, large

238 gnaling that is expressed as different brain phosphoprotein profiles.

239 Phosphoprotein profiling identified diverse phosphorylat

240 demonstrates that proteins and particularly phosphoproteins provide information for predicting drug

241 in live cells and has future applications in phosphoprotein purification and analysis.

242 rotein (NT) and the C-terminal domain of the phosphoprotein (PX).

243 C8 recognition motif within the rabies virus phosphoprotein (RavP) result in completely nonlethal vir

244 pd and the host VASP (vasodilator-stimulated phosphoprotein) recruited to the bacterial cell surface

245 he role of Synapsin, a conserved presynaptic phosphoprotein regulating the balance between the reserv

246 proteomic analyses demonstrate enrichment of phosphoproteins related to the epidermal growth factor (

247 By focusing on a specific matrix phosphoprotein reporter, we also demonstrate that phosph

248 beta-Casein, a phosphoprotein representing 37% of the bovine milk casei

249 Additionally, in the case of a phosphoprotein, results were corroborated using the P tr

250 logy analysis of TOPBP1- and ETAA1-dependent phosphoproteins revealed TOPBP1 to be a primary ATR acti

251 re epilepsy susceptibility genes that encode phosphoproteins reversibly associated with synaptic vesi

252 ysis of peptides, phosphopeptides, proteins, phosphoproteins, ribonucleoprotein assemblies, and large

253 The secretory Ca-binding phosphoprotein (SCPP) gene cluster at 4q13 encodes struc

254 Using a phosphoprotein-screening array, we found that Benzyl Iso

255 rylation of the VASP (vasodilator-stimulated phosphoprotein) Ser239 residue which, in turn, reduced n

256 We also identify new interactions between phosphoprotein signaling and cellular energy processes t

257 energy potential even as glucose uptake and phosphoprotein signaling is repressed.

258 al performance via the PDE4D/PRKAR1alpha/PKA phosphoprotein signaling pathway.

259 GRP levels by 6 to 12 hours and also altered phosphoprotein signaling pathways at 24 hours post-RT.

260 ity as confirmed by SDS-PAGE analysis with a phosphoprotein-specific stain and mass spectrometry anal

261 size several phosphoproteins and demonstrate phosphoprotein structure determination and synthetic pro

262 ively impair PLK1 binding to the kinetochore phosphoprotein substrate PBIP1, but not to the centrosom

263 ruits protein phosphatase 1 (PP1) to certain phosphoprotein substrates.

264 a functional complex with the SV-associated phosphoprotein synapsin, previously implicated in SV clu

265 l approach was used to identify novel mTORC2 phosphoprotein targets in actively invading cancer cells

266 The translocated actin recruiting phosphoprotein (Tarp) is a multidomain type III secreted

267 ribution of Synapsin I (SynI), a presynaptic phosphoprotein that controls the availability of synapti

268 omplex is similar to that of a related virus phosphoprotein that does not bind LC8, suggesting that w

269 MAF1 is a phosphoprotein that plays a critical role in cell growth

270 Synapsin III (SynIII) is a neuron-specific phosphoprotein that plays a unique role in neuronal deve

271 s (HCV) nonstructural protein 5A (NS5A) is a phosphoprotein that plays key, yet poorly defined, roles

272 NPM1 (nucleophosmin 1) is a nucleolar phosphoprotein that regulates many cellular processes, i

273 protein 1 (CARP-1 or CCAR1) is a perinuclear phosphoprotein that regulates signaling induced by antic

274 s in alpha-casein, an approximately 23.5 kDa phosphoprotein that showed eight of nine known phosphory

275 Phosducin (Pdc) is a conserved phosphoprotein that, when unphosphorylated, binds with h

276 RPLP1/2 are phosphoproteins that bind the ribosome through interacti

277 napsin family of synaptic vesicle-associated phosphoproteins that is precociously expressed in neuron

278 tabolites, associated metabolic enzymes, and phosphoproteins, the resultant data provided input for a

279 capture, enrichment, and detection of intact phosphoproteins toward a comprehensive analysis of the p

280 residues at the C-terminus of the nucleolar phosphoprotein Treacle.

281 Specifically, we measured 14 phosphoproteins under 43 different perturbed conditions

282 MVC NP1 is a 22-kDa nuclear phosphoprotein unique to the genus Bocaparvovirus of the

283 th the average number of predictor genes per phosphoprotein used by the teams ranging from 3 to 124.

284 ed phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and CREB.

285 Vasodilator-stimulated phosphoprotein (VASP) and Ena-VASP-like (EVL) are cytosk

286 Vasodilator-stimulated phosphoprotein (VASP) can catalyze actin polymerization

287 sophila enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) homology 1 (EVH1) domains.

288 tion of Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP), a family of conserved actin-elong

289 age overexpression of vasodilator-stimulated phosphoprotein (VASP), a key downstream mediator of intr

290 The HSV type 1 tegument virion phosphoprotein (VP) 11/12 (VP11/12) is a major Ag target

291 y member A (RhoA) and vasodilator-stimulated phosphoprotein was increased in response to 8-CPT-cGMP t

292 147 microenvironment and the CD147-dependent phosphoproteins was generated and led to the identificat

293 nd phosphorylation of vasodilator-stimulated phosphoprotein were determined.

294 total of 1,953 mRNAs, 187 proteins, and 131 phosphoproteins were differentially expressed (DE) betwe

295 phosphopeptides belonging to 3163 different phosphoproteins were efficiently identified with high-th

296 f transcripts and their encoded proteins and phosphoproteins were highly congruent.

297 ion of DARPP-32 (dopamine and cAMP-regulated phosphoprotein), which is expressed in dopaminoceptive n

298 NHERF1 is a phosphoprotein with 40 Ser and Thr residues.

299 Bone sialoprotein (BSP) is an acidic phosphoprotein with collagen-binding, cell attachment, a

300 ofiling identified a set of PfCRK4-regulated phosphoproteins with greatest functional similarity to C